Blog

Campus Messages

An archive of email messages sent to the entire UCSF community by the Chancellor and members of the Chancellor's Cabinet.

June 7, 2016
Leadership

Dear Colleagues:

I am pleased to announce that, following a rigorous national search, Paul Jenny has accepted the position of UCSF Senior Vice Chancellor for Finance and Administration, a role critical to supporting the infrastructure that helps advance UCSF’s mission of patient care, education, research, and community service.

Mr. Jenny, current senior vice president of planning and management at the University of Washington (UW), has extensive financial and operational experience, as well as an in-depth knowledge of the dynamics of a renowned higher education institution, making him extremely well suited for the senior vice chancellor position. This move brings Mr. Jenny back into the University of California fold. He worked from 2004 – 2008 at UC Berkeley, where he served as associate vice chancellor—budget and resource planning and previously as assistant vice chancellor—budget.

Mr. Jenny’s career spans more than twenty years. During his tenure at UW, he has been directly responsible for the financial and business strategies of several areas, including finance modernization, capital building and engineering, administration transformation, and resource allocation modeling. Prior to his years at UC Berkeley, he was at the University of Alaska, the Brookings Institute, and Loyola University New Orleans.

Interim Senior Vice Chancellor Teresa Costantinidis has skillfully guided the financial and administrative services (FAS) organization during this transition period while the year-long search was being conducted. Teresa has my abiding appreciation for her valuable and insightful contributions to the university. I am deeply grateful for her steadfast leadership of key...

Read more »
November 23, 2015
Advocacy
Leadership

Dear Colleagues,

I am writing to share some exciting news about a new position that has been established at UCSF, Vice Chancellor for Science Policy and Strategy. We are currently the #1 public recipient of NIH funding, having a distinct reputation for innovation and discovery. However, as we all know, the funding environment for science and research, as well as general public opinion, can be tenuous and volatile. To sustain and advance our mission, demonstrating proactive leadership in setting and influencing science strategy and public policy will be essential in the immediate and near future. This new position has been created to help UCSF do this.

I am very pleased to announce that Keith Yamamoto PhD, has been selected to serve in this vital role effective immediately. The Vice Chancellor for Science Policy and Strategy (VC-SPS), who will report directly to the Chancellor, will develop, oversee and implement policy, strategy and direction for UCSF, specifically with respect to the biomedical sciences. Working with the UCSF leadership and scientific community, the VC-SPS will engage with state and federal government agencies and other entities that impact scientific policy and control and disburse resources that are needed to translate policy into action. With the objective of influencing and shaping public policy for the future of life sciences, the VC-SPS will represent the full range of science-related interests of UCSF faculty, develop and articulate UCSF scientific strategies, and convey these interests and strategies to the appropriate entities in Washington, DC; Sacramento; and elsewhere. The position of VC-SPS will work closely with the Vice Chancellor – Strategic...

Read more »
May 25, 2015
Leadership

Dear Colleagues:

I am very pleased to announce the appointment of Talmadge E. King, Jr., MD, as our new Dean of the UCSF School of Medicine and Vice Chancellor – Medical Affairs, effective July 1.

After a national search for a new dean to carry on the school’s legacy of excellence, we have found the best leader here among our own community. Chair of the Department of Medicine, Dr. King’s stellar career and tenure at UCSF extends back to 1997. His focus in patient care is interstitial lung diseases, in particular idiopathic pulmonary fibrosis, sarcoidosis, connective tissue disease, hypersensitivity pneumonitis, drug-induced lung fibrosis and other rare diffuse lung disorders. Dr. King's research interests include pathogenesis, diagnosis and management of inflammatory and immunologic lung disease.

Consistently ranked among the nation’s top medical schools, the UCSF School of Medicine has never been stronger, and we have identified the ideal individual to guide it into the future. Talmadge is both an inspirational leader and an international expert in his field, and he will provide a clear course for the school as it not only navigates but continues to thrive in the changing world of health care.

I am deeply grateful to Dr. Bruce Wintroub for his extraordinary service as interim dean during the search process. He has ably led both the School of Medicine and the Department of Dermatology during this period. I also thank the members of the search committee, led by Drs. Catherine Lucey and Shaun Coughlin, for their investment of time that has resulted in this exceptional selection.

Please join me in congratulating Talmadge on his new role in leading the School of...

Read more »
February 19, 2015
Leadership

Dear Colleagues:

Senior Vice Chancellor John Plotts has informed me that he plans to retire as of June 30, 2015. John has provided the University of California with nearly twenty years of exemplary service, beginning at the UC Office of the President and, since 2010, at UCSF.

His impeccable values and integrity, coupled with his extensive financial and operational experience and in-depth knowledge of the University of California system, equipped him superbly to fulfill and confront the considerable responsibilities and challenges inherent to the position of UCSF senior vice chancellor for finance and administration. He has led profound changes in our UCSF infrastructure that have greatly improved our financial management and integrated key functions of the campus and medical center. In addition, he has been a tireless advocate for UCSF within the university. We will miss his ability to find solutions to the most difficult problems as well as the genuine collegiality and warmth that he exhibits every day.

John always puts the interests of the university and the faculty, students and patients first. He demonstrates remarkable leadership to his organization comprising a diverse portfolio of units: Audit Services, Budget and Resource Management, Campus Life Services, Campus Planning, Capital Programs, Controller’s Office, Human Resources, IT, Procurement, Program Management Office, Real Estate Services, and the UCSF Police Department. These teams provide the foundation upon which we operate, and I am grateful to John for his expertise and strategic management of university resources.

Please join me in thanking John for his devotion and excellent service to UC and our UCSF...

Read more »
February 11, 2015
Leadership

Dear Colleagues:

I am pleased to announce the appointment of Theresa O’Lonergan, PhD, MA, as UCSF’s next Associate Vice Chancellor/Chief Ethics and Compliance Officer (CECO). Terri’s appointment is effective March 1, 2015, and she will report directly to me, as well as to Sheryl Vacca, Senior Vice President – Ethics, Compliance, and Audit Services in the Office of the President. Her office will be based at Laurel Heights.

The position of Chief Ethics and Compliance Officer is a critical role for UCSF, providing leadership, direction and oversight for the UCSF Ethics and Compliance Program. In her capacity as CECO, Terri will be responsible for overseeing and implementing key compliance programs that ensure that UCSF fulfills its missions of high-quality research, clinical care and teaching while preventing fraud, abuse, and waste. She will be reaching out to leaders across UCSF to assess needs, risks and issues toward developing sustainable and strategic solutions associated with the challenging and complex nature of regulatory compliance.

Given her extensive background in the field of ethics and compliance, Terri is ideal for this role. She has a diverse career path that includes a leadership position at the University of Colorado, Anschutz Medical Center, where she had oversight responsibilities for research and ethics in its adult and pediatric research centers. Most recently, Terri was National Director of Research Compliance and Research Integrity Officer for Catholic Health Initiatives – a large national health system that includes community and tertiary care facilities, academic medical centers and insurance carriers. In this function, she built compliance infrastructures...

Read more »
January 28, 2015
Leadership

Dear Colleagues,

I am very pleased to announce that UC President Janet Napolitano has approved the appointment of Dan Lowenstein, MD, as the next executive vice chancellor and provost at UCSF.

Dan will collaborate with other members of my leadership team and me to develop and implement campus priorities across our mission areas of research, education, and patient care.

An internationally renowned UCSF physician-scientist specializing in epilepsy research and an award-winning medical educator, Dan is a champion on issues related to cultural diversity and civil rights. He exemplifies excellence in all aspects of our mission and has a deep commitment to our community and its success. His principles align closely with those of UCSF, and I am very glad to have him join me in leading this great University.

Dan succeeds Jeffrey A. Bluestone, PhD, who has done a superb job of guiding and setting priorities within the research and academic enterprise, including developing a visionary precision medicine platform. Jeff has made significant contributions toward the advancement of a broad and innovative approach to advance the translation of UCSF discoveries into public benefit, and I am deeply grateful to him for his leadership.

You can read more about this appointment at: http://www.ucsf.edu/news/2015/01/122921/driven-science-humanism-and-service-dan-lowenstein-joins-ucsf-leadership-team. Please join me in congratulating Dan in his new role.

Sincerely,
Sam Hawgood, MBBS
Chancellor
Arthur and Toni Rembe Rock...

Read more »
January 14, 2015
Leadership

Dear Colleagues,

We are excited to announce that we have successfully recruited Atul Butte, MD, PhD, a world-famous leader in medical technology. Atul will lead a new UCSF Institute for Computational Health Sciences. This institute will be key in mining the flow of health data to find effective cures faster and help fulfill the promise of precision medicine.

A renowned expert in pediatrics and medical informatics at Stanford University, Atul brings with him a rare combination of deep knowledge in medicine and biomedical research and in technological fluency. He will join us on April 1, 2015. We are delighted to welcome Atul to UCSF.

Please read details in this press release.

Sincerely,

Sam Hawgood, MBBS
Chancellor, Arthur and Toni Rembe Rock Distinguished Professor

Bruce Wintroub, MD
Interim Dean, School of Medicine

October 24, 2014
Leadership

Dear Colleagues,

After nearly five years of outstanding service to UCSF as Executive Vice Chancellor and Provost (EVCP), Jeff Bluestone has informed me of his intention to step down. He will be focusing on his exciting research program in the Diabetes Center, while continuing to assist me and the University in a number of strategic ways.

As EVCP, Jeff served as our campus chief academic officer, guiding the research and academic enterprise wisely and carefully during a challenging recessionary period as well as advancing campus research, educational and strategic priorities in close collaboration with the Chancellor and the campus leadership team.

In the role of EVCP, Jeff led many significant initiatives of long-term strategic value to UCSF. Early in his tenure, Jeff led a highly successful effort to secure major funds through the American Recovery and Investment Act, enabling the campus to maintain its research momentum. Jeff has actively overseen the development of a strong core infrastructure and operations to support our faculty in their sponsored research activities, directed a strong ethics and compliance program, and created and managed a technology fund while enhancing the technology transfer office to promote robust industry and academic partnerships. His vision for and management of the high impact Mid-Career Faculty Recruitment Fund have helped departments recruit outstanding faculty to UCSF. Jeff has worked collaboratively with others toward helping set our research priorities, including developing a visionary precision medicine platform and establishing campuswide space principles that will serve UCSF well for years to come. Jeff‘s determination has helped us...

Read more »
October 24, 2014
Leadership

Dear Colleagues,

After nearly five years of outstanding service to UCSF as Executive Vice Chancellor and Provost (EVCP), Jeff Bluestone has informed me of his intention to step down. He will be focusing on his exciting research program in the Diabetes Center, while continuing to assist me and the University in a number of strategic ways.

As EVCP, Jeff served as our campus chief academic officer, guiding the research and academic enterprise wisely and carefully during a challenging recessionary period as well as advancing campus research, educational and strategic priorities in close collaboration with the Chancellor and the campus leadership team.

In the role of EVCP, Jeff led many significant initiatives of long-term strategic value to UCSF. Early in his tenure, Jeff led a highly successful effort to secure major funds through the American Recovery and Investment Act, enabling the campus to maintain its research momentum. Jeff has actively overseen the development of a strong core infrastructure and operations to support our faculty in their sponsored research activities, directed a strong ethics and compliance program, and created and managed a technology fund while enhancing the technology transfer office to promote robust industry and academic partnerships. His vision for and management of the high impact Mid-Career Faculty Recruitment Fund have helped departments recruit outstanding faculty to UCSF. Jeff has worked collaboratively with others toward helping set our research priorities, including developing a visionary precision medicine platform and establishing campuswide space principles that will serve UCSF well for years to come. Jeff‘s determination has helped us...

Read more »
October 14, 2014
Leadership

Dear Colleagues:

I am pleased to announce that Jennifer R. Grandis, MD, has accepted the position of Associate Vice Chancellor—Clinical and Translational Research (AVC-CTR). Dr. Grandis will begin service in her new post in January 2015 while also holding a faculty appointment as Professor of Otolaryngology-Head and Neck Surgery.

This is a critical role for UCSF given today’s rapidly changing landscape of research and patient care that requires the university to have a comprehensive and robust translational and clinical research infrastructure that supports the research and clinical needs of the future. Jennifer will lead and shape the strategic direction for broad elements of our clinical and translational research enterprise including the Clinical & Translational Institute (CTSI). In addition, her responsibilities include serving as a liaison to national committees in the field and overseeing all aspects of clinical trials infrastructure and processes in the EVCP organization.Jennifer will be collaborating with multiple entities and other leaders on campus, including the Medical Center, the four Schools and Graduate Division, and key ORUs and centers on campus.

Jennifer comes to UCSF from the University of Pittsburgh, where she is currently a UPMC Endowed Chair in Head and Neck Cancer Surgical Research and Distinguished Professor of Otolaryngology and Pharmacology & Chemical Biology. She leads the Head and Neck Cancer Program and is Vice Chair for Research in the Department of Otolaryngology. Additionally, she is Health Sciences Assistant Vice Chancellor for Research Program Integration. Her research areas include precision medicine approaches, signal transduction,...

Read more »

Pages